Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Blocking mTORC1 reduces skin tumor growth in mice.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Akt2 and SGK3 are both important for normal hair growth and development.

COX-2 levels change during the hair cycle and affect skin and hair growth.

Kainar syndrome symptoms may be linked to nuclear test exposure effects.

Human tissue kallikreins help regulate skin barrier functions and affect skin health.

Candlenut plants in Karo have common traits and varied kinship, with MTB1 and MTB2 being closest.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Keratin 17 is crucial for cell growth in wound healing by aiding protein synthesis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Krox20 (Egr2) is important for the function of epithelial stem cells.